These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27442966)

  • 1. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
    Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
    Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
    Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
    J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
    Nakanuma Y; Uchida T; Sato Y; Uesaka K
    Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma.
    Bankov K; Döring C; Schneider M; Hartmann S; Winkelmann R; Albert JG; Bechstein WO; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Walter D
    Clin Transl Gastroenterol; 2018 Apr; 9(4):151. PubMed ID: 29712892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the diagnostic yield of controllable biopsy-forceps for biliary strictures.
    Inoue T; Kitano R; Kobayashi Y; Ishii N; Sakamoto K; Ohashi T; Nakade Y; Sumida Y; Ito K; Nakao H; Yoneda M
    Scand J Gastroenterol; 2018 May; 53(5):598-603. PubMed ID: 29183203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative assessment of longitudinal extension of cholangiocarcinoma with peroral video-cholangioscopy: a prospective study.
    Nishikawa T; Tsuyuguchi T; Sakai Y; Sugiyama H; Kishimoto T; Ohtsuka M; Miyazaki M; Yokosuka O
    Dig Endosc; 2014 May; 26(3):450-7. PubMed ID: 23981193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of neutrophil distribution in cholangiocarcinoma.
    Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
    World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review.
    Navaneethan U; Hasan MK; Lourdusamy V; Njei B; Varadarajulu S; Hawes RH
    Gastrointest Endosc; 2015 Oct; 82(4):608-14.e2. PubMed ID: 26071061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma.
    Principe A; Ercolani G; Bassi F; Paolucci U; Raspadori A; Turi P; Beltempo P; Grazi GL; Cavallari A
    Hepatogastroenterology; 2003; 50(53):1246-9. PubMed ID: 14571710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2022 Apr; 80(5):859-868. PubMed ID: 35076959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
    Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
    Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
    Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Liu X; Sanaka MR; Jang S; Vargo JJ; Parsi MA
    Dig Dis Sci; 2013 Oct; 58(10):2986-92. PubMed ID: 23828141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
    Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
    Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma.
    Liu R; Cox Rn K; Siddiqui A; Feurer M; Baron T; Adler DG
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):127-33. PubMed ID: 24780947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease.
    Han JY; Ahn KS; Baek WK; Suh SI; Kim YH; Kim TS; Kang KJ
    Surg Oncol; 2020 Sep; 34():174-181. PubMed ID: 32891325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
    Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
    Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.